NCT00151697View on ClinicalTrials.gov

LANN-study: Lantus, Amaryl, Novorapid, Novomix Study

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 31, 2005

Conditions

Diabetes Mellitus Type II

Interventions

DRUG

Novomix 30

DRUG

Novorapid and Amaryl

DRUG

Lantus

Trial Locations (1)

6800 TA

Rijnstate Hospital, Arnhem

All Listed Sponsors

lead

Rijnstate Hospital

OTHER

NCT00151697 - LANN-study: Lantus, Amaryl, Novorapid, Novomix Study | Biotech Hunter | Biotech Hunter